Market Opportunity in the G-Protein Coupled Receptors GPCRs Target Space

G-protein coupled receptors (GPCRs) have proven to be a highly amenable target class to successful therapeutic intervention via small-molecule drugs. There are 324 distinct molecular drug targets for all classes of approved pharmaceuticals of which 25 percent modulate GPCRs.

The therapeutic utility of GPCR agonists and antagonists across a broad disease space has lead to the development of a number of targeted drugs. The drugs are applied to the following diseases:

Asthma

Cardiovascular Disease

Central Nervous System (CNS) Disorders

Pain

Other therapeutic indications

D&MD's Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space: Qualitative and Quantitative Market Metrics is a focused market analysis report that provides the latest analysis of the GPCR target space in terms of druggable targets available, quantitative metrics defining the space, and therapeutic candidates in various clinical stages of the developmental pipeline.

Of the 324 distinct molecular targets for pharmaceuticals, GPCRs represent 25% of the total pharmaceutically-addressed drug targets today and therefore are the most-druggable target family. This D&MD report presents the current state of the GPCR marketplace both qualitatively and in quantitative terms.

Unique Benefits of This Report

Identify key technology drivers through a detailed analysis of the developmental and applicatory technological trends within the GPCRs space

An up-to-date presentation of the key qualitative and quantitative metrics describing the GPCR target space

Quantitative market opportunity for GPCR interrogation/analysis

The current pipeline of GPCR-targeting therapeutics being developed-all current candidates are presented together with their clinical status, drug targets addressed, companies developing these candidates, and likelihood of progression through the developmental pathway

Figures and charts are presented that describe the features/trends in the GPCRs space-useful for business planning, corporate, and investor presentations

Published: January, 2007

Pages: 240 Format PDF
Table of Contents
Price: $4,950.00 / GBP2,475.00